ArticleBMC pulmonary medicine2023

Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality.

Qian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.